ABOUT
LexaGene is a biotechnology company developing automated and sensitive instrumentation for rapid pathogen detection.
TECHNOLOGY
Our breakthrough technology will transform how pathogens are detected and deliver results in about an hour.
LATEST NEWS
15 August 2017 – LexaGene names life sciences veteran Manohar Furtado to the board of directors. New director brings extensive human health and safety leadership experience to the company.
Innovation in the Making
Imagine a new way of testing on site for multiple pathogens that uses customized genetic screening, doesn’t requite a skilled technician,
and returns results in just one hour. See what’s new with LexaGene and how we are changing the future of pathogen detection.
Introducing the LX6
At a recent conference, LexaGene unveiled our LX6 alpha prototype to get early feedback from the food safety market.
Company Presentation
We are commercializing the first ‘open-access’ instrument for pathogen detection, allowing users an on-site instrument to target any gene sequence of interest, and return results in about an hour.
LexaGene on Fox
Tune in to watch a feature on LexaGene airing soon on Fox Business Network!
Saturday 26 August @ 5pmET and 9 September @ 5pmET
Food Safety
Food industry news site Food Quality News featured LexaGene in a recent article, interviewing Dr. Jack Regan about the expected applications of the technology in the food processing market and beyond.